drugset / Trial / NCT06954025

High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD

NCT06954025

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.

Timeline

Start
2025-05-16
Primary completion
2026-12
Completion
2027-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Midomafetamine Unknown 120 mg